INAB READ THE FULL INAB RESEARCH REPORT IN8bio, Inc (NASDAQ:INAB) updates survival data for its INB-100 trial in a February ...

Shoppers at the Rockbourne Fair put their money where their hearts are, smashing records and raising an impressive £62,081 ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new ...

Following an admission to the authors’ centre with severe anaemia, duodenal biopsy confirmed the diagnosis of Whipple’s ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ivan de Kouchkovsky discussing the impact of baseline PSMA PET in patients with metastatic ...

Novant Health Inc. pitch to investors features two ambitious initiatives: the first: tripling annual revenue from $10 billion ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Joseph Allen discussing PSA response and survival based on metastatic site in patients with ...

Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.

Last week, we released an Action Alert that provides a number of new advocacy resources on key issues — health care extenders, Medicaid, enhanced premium tax credits, so-called site-neutral payment ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

On Tuesday February 18, at 1 PM, Cape Cod Healthcare will give a presentation on how to manage MyChart accounts at the Center ...